Professional Summary

Professional Overview

Clint L. is an experienced FDA Pharmaceutical International Investigator with a strong background in regulatory compliance, investigative work, and the pharmaceutical industry. He leverages his expertise to ensure the safety and quality of international pharmaceutical products, contributing to the well-being of consumers worldwide.

Current Role

As an FDA Pharmaceutical International Investigator, Clint's primary responsibilities include conducting on-site inspections of international pharmaceutical manufacturing facilities, evaluating compliance with Good Manufacturing Practices (GMP), and investigating potential issues or violations. He collaborates closely with global regulatory agencies to maintain rigorous standards and address any discrepancies identified during his investigations. Clint's work plays a crucial role in safeguarding the integrity of the pharmaceutical supply chain and protecting public health.

Career Progression

Prior to his current role, Clint held various investigative and enforcement positions, including Computer Forensic Examiner/Special Agent at the Alabama Department of Transportation, Revenue Officer at the Internal Revenue Service, and Investigator at the US Office of Personnel Management. These diverse experiences have equipped him with a well-rounded skill set and a deep understanding of regulatory processes, investigative techniques, and data analysis.

Academic Background

Clint holds a Bachelor's degree, though the specific field of study is not provided in the given information.

Areas of Expertise

Clint's areas of expertise include:

• Pharmaceutical industry regulations and compliance

• Investigative techniques and data analysis

• International regulatory affairs

• Quality assurance and control

• Cross-functional collaboration with global agencies

Professional Impact

Throughout his career, Clint has demonstrated a strong commitment to upholding regulatory standards and safeguarding public health. His work as an FDA Pharmaceutical International Investigator has contributed to the identification and resolution of non-compliance issues, ensuring the safety and quality of pharmaceutical products imported into the United States.

Conclusion

With his extensive experience in regulatory enforcement, investigative work, and the pharmaceutical industry, Clint L. is a valuable asset to the FDA's mission of protecting consumers and maintaining the integrity of the global pharmaceutical supply chain. His dedication and expertise continue to make a meaningful impact on public health and safety.